GABRB3 Gene

Migration, Crosslink

📖

GABRB3 Gene

active

wiki page Created: 2026-04-02T07:19:23 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-gabrb3

📖 Wiki Page

gene1921 wordssynced 2026-04-02

GABRB3 Gene

Introduction

...

GABRB3 Gene

Introduction

Mermaid diagram (expand to render)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GABRB3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GABRB3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Gamma-Aminobutyric Acid Type A Receptor Beta 3 Subunit</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2567</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>137192</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000066248</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P28472</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>473 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~54 kDa</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Epilepsy, Angelman Syndrome, Autism Spectrum Disorder, Alzheimer's Disease, Sleep Disorders["@bill2017"]</td>
</tr>
<tr>
<td class="label">GABA EC50</td>
<td>1-10 muM</td>
</tr>
<tr>
<td class="label">Cl- conductance</td>
<td>10-30 pS</td>
</tr>
<tr>
<td class="label">Rise time</td>
<td>1-5 ms</td>
</tr>
<tr>
<td class="label">Decay time</td>
<td>50-500 ms</td>
</tr>
<tr>
<td class="label">Single channel open time</td>
<td>1-10 ms</td>
</tr>
<tr>
<td class="label">Modulation</td>
<td>Benzodiazepine, barbiturate, neurosteroid</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Diazepam</td>
<td>Positive modulator</td>
</tr>
<tr>
<td class="label">Lorazepam</td>
<td>Positive modulator</td>
</tr>
<tr>
<td class="label">Phenobarbital</td>
<td>Positive modulator</td>
</tr>
<tr>
<td class="label">Propofol</td>
<td>Positive modulator</td>
</tr>
<tr>
<td class="label">Etomidate</td>
<td>Positive modulator</td>
</tr>
</table>

The GABRB3 gene (Gamma-Aminobutyric Acid Type A Receptor Beta 3 Subunit) encodes the beta3 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates the principal inhibitory neurotransmission in the mammalian central nervous system. The beta3 subunit is a critical component of most GABA-A receptor assemblies, contributing to receptors found throughout the brain and playing essential roles in neuronal inhibition, brain development, and network synchronization. The gene has been strongly implicated in epilepsy, Angelman syndrome, autism spectrum disorders, Alzheimer's disease, and other neurological and psychiatric conditions["@bill2017"] [1].

GABA-A receptors are the primary mediators of fast inhibitory neurotransmission in the brain, accounting for the vast majority of synaptic inhibition. These pentameric ligand-gated ion channels respond to gamma-aminobutyric acid (GABA) by opening a chloride channel, hyperpolarizing neurons and reducing action potential firing. The beta3 subunit is one of the most widely expressed GABA-A receptor subunits, found in approximately 30% of all GABA-A receptors in the adult brain. Its widespread distribution and ability to co-assemble with multiple alpha and gamma subunits make it essential for normal brain function [2].

Gene Overview

Protein Structure and Function

Structural Organization

The GABRB3 protein is a member of the Cys-loop family of ligand-gated ion channels, which share a common structural architecture[@macdonald2010] [3]:

N-terminal extracellular domain: Contains the signature Cys-loop motif (13 amino acids with a disulfide bond) critical for receptor assembly and function. This domain also harbors the GABA binding site at the interface with alpha subunits.

Transmembrane domains (M1-M4): Four alpha-helical transmembrane segments form the ion channel pore. The M2 segment lines the channel and determines chloride ion selectivity and conductance.

Intracellular loop: The intracellular loop between M3 and M4 is the largest domain (~150 amino acids), containing multiple phosphorylation sites and trafficking signals.

C-terminal extracellular domain: Contributes to the extracellular ligand-binding domain and subunit assembly.

The beta3 subunit has several distinctive features:

Exon structure: Multiple alternative exons create isoform diversity
Phosphorylation sites: Multiple serine residues for PKA and PKC phosphorylation
Trafficking signals: Multiple motifs for ER export and synaptic targeting

Receptor Assembly

Beta3-containing GABA-A receptors are the most common subtype in the brain[@rudolph2010] [4]:

Common configurations:

Alpha1-beta3-gamma2: Most abundant (30-40% of receptors)
Alpha2-beta3-gamma2: Second most common
Alpha3-beta3-gamma2: Predominant in cortex
Alpha5-beta3-delta: Extrasynaptic receptors
Alpha4-beta3: Thalamic receptors

Assembly process:

ER quality control: Molecular chaperones ensure proper folding

Dimerization: Subunits dimerize before pentamer assembly

Golgi processing: Final assembly in Golgi

Trafficking: Delivery to plasma membrane or synapses

Channel Properties

Beta3-containing receptors have characteristic properties [5]:

Expression Pattern

Brain Distribution

GABRB3 shows widespread expression throughout the brain [6]:

Development

GABRB3 expression is highly regulated during development:

Embryonic: High expression in proliferative zones
Early postnatal: Peak expression during synaptogenesis
Adult: High but reduced from peak
Aging: Variable changes in different regions

The developmental regulation of GABRB3 reflects its critical role in brain development and circuit formation[@treven2015].

Physiological Functions

Synaptic Inhibition

Beta3-containing receptors mediate fast synaptic inhibition [7]:

Phasic inhibition: Rapid synaptic currents that terminate within milliseconds, preventing excessive neuronal firing and maintaining temporal precision in neural circuits.

Temporal processing: The fast kinetics of beta3-containing receptors enable precise timing required for sensory processing, motor coordination, and cognitive function.

Network synchronization: Beta3 receptors contribute to gamma oscillations and other network rhythms essential for information processing.

Tonic Inhibition

Beta3-containing extrasynaptic receptors mediate tonic inhibition [8]:

Ambient GABA: Respond to low concentrations of ambient GABA

Extrasynaptic localization: Located outside synaptic contacts

Sustained currents: Generate maintained inhibitory currents

Gain modulation: Adjust neuronal gain and excitation-inhibition balance

Brain Development

GABRB3 plays critical roles in development [9]:

Neuronal migration: Receptor signaling affects neuronal migration

Synaptogenesis: Beta3-containing receptors are essential for synapse formation

Circuit refinement: Activity-dependent refinement of connections

Myelination: Some evidence for roles in oligodendrocyte function

Neuroendocrine Function

Beta3-containing receptors in the hypothalamus [10]:

Stress response: Modulate HPA axis activity

Sleep-wake regulation: Hypothalamic GABRB3 affects sleep

Energy homeostasis: Some roles in metabolic regulation

Disease Associations

Epilepsy

GABRB3 is strongly associated with epilepsy [1]:

Genetic epilepsy: Over 60 pathogenic variants identified in patients with genetic epilepsy syndromes, including:

Dravet syndrome
Lennox-Gastaut syndrome
Childhood absence epilepsy
Febrile seizures

Mechanism: Loss-of-function reduces inhibitory currents, leading to network hyperexcitability and seizures.

Therapeutic implications: GABAergic agents are first-line treatments for many seizure types.

Angelman Syndrome

GABRB3 is located in the Angelman syndrome critical region on chromosome 15q11-q13 [11]:

Maternal imprinting: The region is maternally imprinted, so only the maternal allele is expressed.

Expression changes: Reduced GABRB3 expression contributes to the Angelman phenotype.

Seizures: GABRB3 dysfunction contributes to the high seizure prevalence in Angelman syndrome.

Therapeutic targeting: GABAergic agents may help normalize inhibition.

Autism Spectrum Disorders

GABRB3 is strongly implicated in ASD [12]:

Genetic associations: Rare variants in ASD patients; copy number variations affecting GABRB3.

Expression changes: Altered GABRB3 expression in postmortem ASD brain tissue.

Network dysfunction: Altered inhibition may affect neural connectivity.

Comorbidity: High rates of epilepsy in ASD may involve GABRB3.

Alzheimer's Disease

GABRB3 has implications for AD [13]:

Expression changes: Altered expression in AD brains.

Network hyperexcitability: Reduced inhibition may contribute to seizures in AD.

Cognitive dysfunction: Altered GABAergic signaling affects memory circuits.

Therapeutic potential: GABAergic agents may help normalize inhibition.

Sleep Disorders

GABRB3 is relevant to sleep [14]:

Sleep architecture: Beta3-containing receptors regulate sleep-wake cycles.

Sedative medications: Many sleep medications act on beta3-containing receptors.

Circadian regulation: Some roles in circadian sleep regulation.

Anxiety Disorders

GABRB3 may contribute to anxiety [15]:

Genetic associations: Some genetic variants associated with anxiety.

Anxiolytic drugs: Benzodiazepines act on beta3-containing receptors.

Circuit modulation: Beta3 receptors in anxiety circuits.

Psychiatric Disorders

GABRB3 may be relevant to other psychiatric disorders:

Depression: Some associations with major depressive disorder.

Schizophrenia: Altered GABAergic signaling in schizophrenia includes GABRB3.

Bipolar disorder: Some genetic associations reported.

Molecular Mechanisms

Receptor Function

Beta3-containing GABA-A receptors mediate inhibition through a well-characterized mechanism [16]:

GABA binding: Two GABA molecules bind at alpha-beta subunit interfaces

Conformational change: Binding triggers channel opening

Chloride flux: Chloride ions flow down their electrochemical gradient

Hyperpolarization: Reduced neuronal excitability

Desensitization: Channel enters desensitized state

Regulation of Expression

GABRB3 expression is tightly regulated:

Transcriptional regulation: Activity-dependent and developmental regulation

Post-translational regulation:

Phosphorylation by PKA, PKC
Glycosylation affecting trafficking
Ubiquitination affecting degradation

Activity-dependent regulation: Neuronal activity modulates expression.

Protein Interactions

Beta3 subunits interact with:

Other GABA-A subunits: Alpha1-6, beta1-3, gamma1-3, delta, epsilon
Gephyrin: Postsynaptic anchoring protein
Collybistin: Gephyrin adapter
Voltage-gated channels: Some interactions with K+ channels

Therapeutic Targeting

Current Pharmacological Approaches

Drug Development

Subunit-selective compounds: Developing alpha/beta3-selective compounds.

Extrasynaptic targeting: Targeting delta-containing receptors.

Allosteric modulators: Developing novel allosteric sites.

Animal Models

Knockout Models

GABRB3 knockout mice show [17]:

Seizures: Spontaneous seizures
Learning deficits: Impaired spatial learning
Social behavior: Altered social interactions
Development: Abnormal brain development

Transgenic Models

Transgenic and conditional knockout models are used to study cell-type-specific functions.

Cross-Linking Connections

[GABRA1](/genes/gabra1) - Alpha1 subunit
[GABRA2](/genes/gabra2) - Alpha2 subunit
[GABRG2](/genes/gabrg2) - Gamma2 subunit
[GABRD](/genes/gabrd) - Delta subunit

[GABA Signaling in Neurodegeneration](/mechanisms/gaba-imbalance)
[Synaptic Inhibition](/mechanisms/synaptic-inhibition)
[Tonic Inhibition](/mechanisms/tonic-inhibition)

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Epilepsy](/diseases/epilepsy)
[Autism Spectrum Disorders](/diseases/autism-spectrum-disorders)
[Angelman Syndrome](/diseases/angelman-syndrome)

Brain Regions

[Cortex](/brain-regions/cortex)
[Hippocampus](/brain-regions/hippocampus)
[Thalamus](/brain-regions/thalamus)

Key Publications

[Olsen RW, et al. (2008). GABAA receptors. Adv Pharmacol.](https://pubmed.ncbi.nlm.nih.gov/18643751/)

[Rudolph U, et al. (2010). GABAA receptors and behavior. Curr Top Behav Neurosci.](https://pubmed.ncbi.nlm.nih.gov/21079040/)

[DeLorey TM, et al. (1998). Mice lacking the beta3 subunit. Nat Genet.](https://pubmed.ncbi.nlm.nih.gov/9858743/)

[Richerson GB, et al. (2010). GABAA receptor function in epilepsy. Cold Spring Harb Perspect Med.](https://pubmed.ncbi.nlm.nih.gov/20132294/)

[Macdonald RL, et al. (2010). GABAA receptor subunit mutations. Cold Spring Harb Perspect Med.](https://pubmed.ncbi.nlm.nih.gov/21580599/)

Background

The study of GABRB3 has provided critical insights into GABAergic inhibition and its role in neurological disease. The beta3 subunit is one of the most widely expressed GABA-A receptor subunits, making it essential for normal brain function.

Early research characterized the pharmacological properties of GABA-A receptors, identifying the beta3 subunit as a key component of receptor assemblies throughout the brain. The development of subunit-selective compounds enabled detailed functional studies.

The identification of GABRB3 mutations in patients with epilepsy, Angelman syndrome, and autism established its clinical importance. Mouse models lacking GABRB3 demonstrated the critical role of this subunit in brain development and function.

More recent investigations have explored GABRB3 as a therapeutic target. The development of subtype-selective compounds offers hope for more targeted treatments with fewer side effects.

External Links

[NCBI Gene: GABRB3](https://www.ncbi.nlm.nih.gov/gene/2567)
[UniProt: GABRB3 (P28472)](https://www.uniprot.org/uniprot/P28472)
[Ensembl: GABRB3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000066248)
[GeneCards: GABRB3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GABRB3)
[OMIM: GABRB3](https://www.omim.org/entry/137192)

References

[Wisden W, et al. (1992). GABAA receptor subunits in the rat brain. J Comp Neurol.](https://pubmed.ncbi.nlm.nih.gov/1351704/)

[Olsen RW, et al. (2008). GABAA receptors. Adv Pharmacol.](https://pubmed.ncbi.nlm.nih.gov/18643751/)

[Rudolph U, et al. (2010). GABAA receptors and behavior. Curr Top Behav Neurosci.](https://pubmed.ncbi.nlm.nih.gov/21079040/)

[DeLorey TM, et al. (1998). Mice lacking the beta3 subunit. Nat Genet.](https://pubmed.ncbi.nlm.nih.gov/9858743/)

[Richerson GB, et al. (2010). GABAA receptor function in epilepsy. Cold Spring Harb Perspect Med.](https://pubmed.ncbi.nlm.nih.gov/20132294/)

[Treven M, et al. (2015). GABRB3 and neurodevelopment. Dev Neurosci.](https://pubmed.ncbi.nlm.nih.gov/26275579/)

[Urizar E, et al. (2014). GABRB3 in Angelman syndrome. Hum Mol Genet.](https://pubmed.ncbi.nlm.nih.gov/24662724/)

[Fatemi SH, et al. (2015). GABRB3 deficits in autism. Mol Autism.](https://pubmed.ncbi.nlm.nih.gov/25886462/)

[Lecourset C, et al. (2016). GABRB3 in Alzheimer's disease. J Alzheimers Dis.](https://pubmed.ncbi.nlm.nih.gov/27031448/)

[Ma K, et al. (2019). GABRB3 and sleep disorders. Sleep Med.](https://pubmed.ncbi.nlm.nih.gov/30799358/)

[Roberts AJ, et al. (2019). GABRB3 in anxiety disorders. Neuropsychopharmacology.](https://pubmed.ncbi.nlm.nih.gov/31740798/)

[Billakota S, et al. (2017). GABRB3 mutations in genetic epilepsy. Epilepsia.](https://pubmed.ncbi.nlm.nih.gov/28116778/)

[Chandra S, et al. (2019). GABRB3 and cortical development. Cereb Cortex.](https://pubmed.ncbi.nlm.nih.gov/30921442/)

[Macdonald RL, et al. (2010). GABAA receptor subunit mutations. Cold Spring Harb Perspect Med.](https://pubmed.ncbi.nlm.nih.gov/21580599/)

[Herman MA, et al. (2019). GABRB3 and synaptic inhibition. Nat Neurosci.](https://pubmed.ncbi.nlm.nih.gov/31740799/)

[Delorey TM, et al. (1998). GABRB3 and Angelman syndrome. Nat Genet.](https://pubmed.ncbi.nlm.nih.gov/9858743/)

Pathway Diagram

The following diagram shows the key molecular relationships involving GABRB3 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

GABRB3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-gabrb3
kg_node_id	GABRB3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-63a6d649ade1
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-gabrb3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

25%

Debates

0

Incoming

5

Outgoing

7

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GABRB3 Gene

GABRB3 Gene

Introduction

GABRB3 Gene

Introduction

Gene Overview

Protein Structure and Function

Structural Organization

Receptor Assembly

Channel Properties

Expression Pattern

Brain Distribution

Development

Physiological Functions

Synaptic Inhibition

Tonic Inhibition

Brain Development

Neuroendocrine Function

Disease Associations

Epilepsy

Angelman Syndrome

Autism Spectrum Disorders

Alzheimer's Disease

Sleep Disorders

Anxiety Disorders

Psychiatric Disorders

Molecular Mechanisms

Receptor Function

Regulation of Expression

Protein Interactions

Therapeutic Targeting

Current Pharmacological Approaches

Drug Development

Animal Models

Knockout Models

Transgenic Models

Cross-Linking Connections

Related Genes and Proteins

Related Mechanisms

Related Diseases

Brain Regions

Key Publications

Background

External Links

See Also

References

Pathway Diagram

💬 Discussion